Home » News » Inspections to detect counterfeit or illegal drugs

Inspections to detect counterfeit or illegal drugs

Murcia Health Authority Intensifies Fight Against Counterfeit Drugs with 650 Inspections

Murcia, Spain – October 30, 2025 – In a significant move to safeguard public health, the Pharmaceutical Management and Care Service (SOAF) of the Ministry of Health in the Region of Murcia has revealed the results of an extensive inspection campaign conducted throughout 2024. A total of 650 inspections were carried out across the entire healthcare product chain, signaling a heightened commitment to combating illegal medicines and ensuring the safety of citizens.

Targeting the Shadow Market: 135 Inspections Focused on Counterfeit Drugs

The SOAF’s efforts weren’t spread thinly. A dedicated 135 inspections specifically targeted the growing threat of counterfeit medicines. Jesús Cañavate, the general director of Planning, Pharmacy and Health Research, emphasized that controlling the supply of these dangerous fakes, monitoring narcotics, and preventing the diversion of prescription drugs – particularly psychotropic and anabolic substances – were top priorities. This isn’t just about stopping criminals; it’s about protecting vulnerable individuals from potentially life-threatening substances.

The problem of counterfeit medicines is a global one, with the World Health Organization estimating that 10% of medicines in low- and middle-income countries are substandard or falsified. While Murcia is a developed region, the interconnected nature of pharmaceutical supply chains means vigilance is paramount. These inspections aren’t just reactive; they’re a proactive defense against a sophisticated and evolving threat.

Beyond Counterfeits: A Comprehensive Approach to Pharmaceutical Safety

The SOAF’s inspection program extends far beyond just counterfeit drugs. The 650 total inspections encompassed a broad spectrum of health products, including medicines for both human and veterinary use, cosmetics, and personal care items. This holistic approach ensures that every stage of the pharmaceutical lifecycle – from manufacturing and storage to distribution and dispensing – adheres to stringent quality and safety standards.

Specifically, 203 inspections were conducted in pharmacies, the frontline of healthcare access for most citizens. Eleven additional inspections focused on wholesale distribution warehouses, critical hubs in the supply chain. This layered approach, combined with close collaboration with the Spanish Agency for Medicines and Health Products (Aemps) and other autonomous communities through the Technical Inspection Committee, is proving effective.

The Importance of Collaboration and National Standards

Cañavate highlighted the “key” role of collaboration in achieving success. The Spanish Agency for Medicines and Health Products (Aemps) provides national oversight and expertise, while the Technical Inspection Committee facilitates information sharing and coordinated action across different regions. This unified front is essential for tackling issues like market control, clinical trial supervision, and the ongoing battle against illegal medicines.

Evergreen Insight: Pharmaceutical regulations are constantly evolving. The European Medicines Agency (EMA) plays a crucial role in harmonizing standards across the EU, ensuring that medicines are safe and effective for all citizens. Staying informed about these regulations is vital for both healthcare professionals and consumers.

The SOAF’s work isn’t simply about enforcing rules; it’s about building trust in the healthcare system. By guaranteeing compliance with legislation regarding product composition, labeling, and rational use, they are actively promoting the health and well-being of the population. This commitment to quality and safety is a cornerstone of a healthy society.

The dedication of the SOAF to protecting citizens through rigorous inspection and collaboration sets a strong example for other regions. As the pharmaceutical landscape continues to evolve, proactive measures like these will be essential to maintaining public trust and ensuring access to safe, effective medicines. For more in-depth coverage of health and pharmaceutical news, stay tuned to Archyde.com.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.